Your browser doesn't support javascript.
loading
Continuous monitoring of physiological data using the patient vital status fusion score in septic critical care patients.
Ohland, Philipp L S; Jack, Thomas; Mast, Marcel; Melk, Anette; Bleich, André; Talbot, Steven R.
Afiliación
  • Ohland PLS; Hannover Medical School, Institute for Laboratory Animal Science, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
  • Jack T; Department of Pediatric Cardiology and Intensive Care Medicine, Hannover Medical School, Hanover, Germany.
  • Mast M; Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Hanover, Germany.
  • Melk A; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hanover, Germany.
  • Bleich A; Hannover Medical School, Institute for Laboratory Animal Science, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
  • Talbot SR; Hannover Medical School, Institute for Laboratory Animal Science, Carl-Neuberg-Straße 1, 30625, Hannover, Germany. talbot.steven@mh-hannover.de.
Sci Rep ; 14(1): 7198, 2024 03 26.
Article en En | MEDLINE | ID: mdl-38531955
ABSTRACT
Accurate and standardized methods for assessing the vital status of patients are crucial for patient care and scientific research. This study introduces the Patient Vital Status (PVS), which quantifies and contextualizes a patient's physical status based on continuous variables such as vital signs and deviations from age-dependent normative values. The vital signs, heart rate, oxygen saturation, respiratory rate, mean arterial blood pressure, and temperature were selected as input to the PVS pipeline. The method was applied to 70 pediatric patients in the intensive care unit (ICU), and its efficacy was evaluated by matching high values with septic events at different time points in patient care. Septic events included systemic inflammatory response syndrome (SIRS) and suspected or proven sepsis. The comparison of maximum PVS values between the presence and absence of a septic event showed significant differences (SIRS/No SIRS p < 0.0001, η2 = 0.54; Suspected Sepsis/No Suspected Sepsis p = 0.00047, η2 = 0.43; Proven Sepsis/No Proven Sepsis p = 0.0055, η2 = 0.34). A further comparison between the most severe PVS in septic patients with the PVS at ICU discharge showed even higher effect sizes (SIRS p < 0.0001, η2 = 0.8; Suspected Sepsis p < 0.0001, η2 = 0.8; Proven Sepsis p = 0.002, η2 = 0.84). The PVS is emerging as a data-driven tool with the potential to assess a patient's vital status in the ICU objectively. Despite real-world data challenges and potential annotation biases, it shows promise for monitoring disease progression and treatment responses. Its adaptability to different disease markers and reliance on age-dependent reference values further broaden its application possibilities. Real-time implementation of PVS in personalized patient monitoring may be a promising way to improve critical care. However, PVS requires further research and external validation to realize its true potential.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Choque Séptico / Sepsis Límite: Child / Humans Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Choque Séptico / Sepsis Límite: Child / Humans Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido